查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1911599

体外膜氧合（ECMO）设备市场规模、份额和成长分析（按组件、模式、患者年龄层、应用、最终用户和地区划分）—2026-2033年产业预测

Extracorporeal Membrane Oxygenation Machine Market Size, Share, and Growth Analysis, By Component, By Modality (Veno-Venous, Veno-Arterial ), By Patient Age Group, By Application, By End-User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 197 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球体外膜氧合（ECMO）设备市场规模预计在 2024 年达到 3.2822 亿美元，从 2025 年的 3.4594 亿美元增长到 2033 年的 5.269 亿美元，在预测期（2026-2033 年）内复合增长率为 5.4%。

由于体外膜氧合（ECMO）在常规治疗方法无效时对治疗严重心臟衰竭衰竭发挥至关重要的作用，全球ECMO设备市场正经历温和成长。推动需求成长的关键因素包括重症监护设施的进步、心肺疾病发病率的上升以及ECMO在临床上的接受度不断提高。 ECMO技术的创新有望提升便携性，采用生物相容性材料，并整合监测系统以应对紧急情况和转运场景。专业ECMO中心的建立和多学科培训计画的实施正在推动ECMO的普及。然而，挑战依然存在，包括高成本、训练有素的专业人员短缺、复杂的管理要求限制了其在专业医院的使用，以及影响市场进入的报销和监管壁垒。

全球体外膜氧合（ECMO）设备市场驱动因素

全球体外膜氧合（ECMO）设备市场的主要驱动因素之一是呼吸系统和心臟疾病的日益普遍，这些疾病需要先进的医疗干预。随着医疗机构不断寻求针对严重肺功能障碍和心臟衰竭患者的有效解决方案，ECMO设备因其在重症监护环境中提供生命维持的能力而日益重要。此外，ECMO技术的进步，例如携带式型号和生物相容性的提高，以及人们对人工器官系统的认识不断加深，都透过改善患者预后和提供更好的治疗方案，显着促进了市场的扩张。

限制全球体外膜氧合（ECMO）设备市场的因素

全球体外膜氧合（ECMO）设备市场的主要限制因素是购买和维护这些设备的高昂成本。 ECMO设备所需的大量投资，以及医护人员培训和配套基础设施的相关费用，都可能成为许多医疗机构，特别是新兴经济体医疗机构的障碍。此外，报销难题和监管障碍也会进一步限制ECMO技术的应用，并阻碍其在重症监护环境中的普及和使用。这种经济负担会限制患者享受ECMO救命治疗的机会，进而影响整个市场的成长。

体外膜氧合（ECMO）设备市场的全球趋势

全球体外膜氧合（ECMO）设备市场正呈现出高度便携、易于操作的系统发展的显着趋势。製造商正致力于开发紧凑、轻巧、可移动的ECMO设备，使其能够在传统加护病房之外有效应用。这项创新使得患者能够在小规模的医疗机构中转运和接受治疗，这对于农村和资源匮乏地区尤其重要。这些可携式系统简化的设置流程提高了ECMO治疗的可及性，最终扩大了患者照护的覆盖范围，并满足了不同医疗环境中的迫切需求。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术评估
  • 监管环境
  • 原料分析

全球体外膜氧合（ECMO）设备市场规模（依组件划分）及复合年增长率（2026-2033）

  • 泵浦
  • 氧合设备
  • 控制器
  • 套管和导管套装
  • 配件和耗材

全球体外膜氧合（ECMO）设备市场规模（按模式和复合年增长率划分）（2026-2033 年）

  • 静脉-静脉（VV）
  • 静脉-动脉（VA）
  • 动静脉（AV）

全球体外膜氧合（ECMO）设备市场规模（依病患年龄层划分）及复合年增长率（2026-2033 年）

  • 新生
  • 儿童
  • 成人

全球体外膜氧合（ECMO）设备市场规模：按应用和复合年增长率划分（2026-2033 年）

  • 呼吸系统疾病
  • 心臟病
  • 体外心肺復苏术（ECPR）

全球体外膜氧合（ECMO）设备市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

  • 医院（加护病房/心臟监护室）
  • 专科诊所
  • 紧急医疗服务

全球体外膜氧合（ECMO）设备市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Medtronic plc
  • Getinge AB
  • LivaNova PLC
  • Terumo Cardiovascular Corporation
  • Nipro Corporation
  • Eurosets Srl
  • Maquet Holding（Getinge Group）
  • CytoSorbents Corporation
  • Medos Medizintechnik AG
  • Microport Scientific Corporation
  • Philips Healthcare（ECLS division）
  • Edwards Lifesciences Corporation
  • Xenios AG
  • Saranas Inc.
  • Oxygen Plus Medical Systems
  • Hemovent GmbH
  • Abiomed Inc.
  • Boston Scientific Corporation
  • Smiths Medical（ICU Life Support Division）
  • Baxter International Inc.

结论与建议

简介目录
Product Code: SQMIG35A3132

Global Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 328.22 Million in 2024 and is poised to grow from USD 345.94 Million in 2025 to USD 526.9 Million by 2033, growing at a CAGR of 5.4% during the forecast period (2026-2033).

The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing gradual growth, driven by its essential role in managing severe cardiac and respiratory failure when conventional treatments fail. Key factors fueling demand include advancements in critical care facilities, rising incidences of cardiopulmonary diseases, and greater clinical acceptance of ECMO. Innovations in ECMO technology are expected to enhance portability, incorporate biocompatible materials, and feature integrated monitoring systems, catering to emergency and transport scenarios. The establishment of specialized ECMO centers and multidisciplinary training programs is bolstering adoption rates. However, challenges remain, such as high equipment costs, a shortage of trained professionals, and complex management requirements that confine usage to specialized hospitals, along with reimbursement and regulatory hurdles impacting market access.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Extracorporeal Membrane Oxygenation Machine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Extracorporeal Membrane Oxygenation Machine Market Segments Analysis

Global Extracorporeal Membrane Oxygenation Machine Market is segmented by Component, Modality, Patient Age Group, Application, End-User and region. Based on Component, the market is segmented into Pumps, Oxygenators, Controllers, Cannula & Tubing Sets and Accessories & Consumables. Based on Modality, the market is segmented into Veno-Venous (VV), Veno-Arterial (VA) and Arterio-Venous (AV). Based on Patient Age Group, the market is segmented into Neonates, Pediatrics and Adults. Based on Application, the market is segmented into Respiratory Disorders, Cardiac Conditions and Extracorporeal Cardiopulmonary Resuscitation (ECPR). Based on End-User, the market is segmented into Hospitals (ICU / Cardiac Care Units), Specialty Clinics and Emergency Medical Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Extracorporeal Membrane Oxygenation Machine Market

One of the key market drivers for the global extracorporeal membrane oxygenation (ECMO) machine market is the growing prevalence of respiratory and cardiac diseases, which demand advanced medical interventions. As healthcare providers increasingly seek effective solutions for patients experiencing severe pulmonary or cardiac distress, ECMO machines have gained prominence for their capability to provide life-sustaining support in critical care settings. Additionally, advancements in ECMO technology, such as portable models and improved biocompatibility, alongside the rising awareness of artificial organ systems, significantly contribute to the market's expansion by enhancing patient outcomes and facilitating better treatment options.

Restraints in the Global Extracorporeal Membrane Oxygenation Machine Market

A significant market restraint for the global extracorporeal membrane oxygenation (ECMO) machine market is the high cost associated with the acquisition and maintenance of these devices. The substantial investment required for ECMO machines, along with the expenses related to necessary training for medical personnel and supporting infrastructure, can be prohibitive for many healthcare facilities, particularly in emerging economies. Additionally, reimbursement challenges and regulatory hurdles can further limit the adoption of ECMO technology, hindering its availability and utilization in critical care settings. This financial burden may restrict access to the life-saving benefits of ECMO for patients, impacting overall market growth.

Market Trends of the Global Extracorporeal Membrane Oxygenation Machine Market

The Global Extracorporeal Membrane Oxygenation (ECMO) Machine market is experiencing a significant trend towards the development of portable and user-friendly systems. Manufacturers are focusing on creating compact, lightweight, and mobile ECMO devices that can be effectively utilized beyond conventional intensive care units. This innovation facilitates the transport and treatment of patients in smaller healthcare facilities, particularly beneficial for rural and resource-limited areas. The streamlined setup process of these portable systems enhances accessibility to ECMO therapy, ultimately broadening the scope of patient care and addressing critical needs in diverse healthcare environments.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape
  • Raw Material Analysis

Global Extracorporeal Membrane Oxygenation Machine Market Size by Component & CAGR (2026-2033)

  • Market Overview
  • Pumps
  • Oxygenators
  • Controllers
  • Cannula & Tubing Sets
  • Accessories & Consumables

Global Extracorporeal Membrane Oxygenation Machine Market Size by Modality & CAGR (2026-2033)

  • Market Overview
  • Veno-Venous (VV)
  • Veno-Arterial (VA)
  • Arterio-Venous (AV)

Global Extracorporeal Membrane Oxygenation Machine Market Size by Patient Age Group & CAGR (2026-2033)

  • Market Overview
  • Neonates
  • Pediatrics
  • Adults

Global Extracorporeal Membrane Oxygenation Machine Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Respiratory Disorders
  • Cardiac Conditions
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Global Extracorporeal Membrane Oxygenation Machine Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals (ICU / Cardiac Care Units)
  • Specialty Clinics
  • Emergency Medical Services

Global Extracorporeal Membrane Oxygenation Machine Market Size & CAGR (2026-2033)

  • North America (Component, Modality, Patient Age Group, Application, End-User)
    • US
    • Canada
  • Europe (Component, Modality, Patient Age Group, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Component, Modality, Patient Age Group, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Component, Modality, Patient Age Group, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Component, Modality, Patient Age Group, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Cardiovascular Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurosets S.r.l.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Maquet Holding (Getinge Group)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CytoSorbents Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medos Medizintechnik AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microport Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare (ECLS division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xenios AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Saranas Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxygen Plus Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hemovent GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abiomed Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (ICU Life Support Division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations